Dr Reddy’s Laboratories and Zydus Lifesciences are recalling certain medicines from the US after USFDA found manufacturing and quality issues. The recalls, affecting muscle relaxant and hepatitis B drugs, are precautionary and classified as moderate-risk (Class II)

New Delhi: Two major Indian pharmaceutical companies, Dr Reddy’s Laboratories and Zydus Lifesciences, are recalling certain medicines from the US market due to manufacturing issues, the US health regulator has said.

According to the latest enforcement report by the US Food and Drug Administration (USFDA), an American subsidiary of Hyderabad-based Dr Reddy’s is recalling 571 vials of Succinylcholine Chloride Injection, a medicine used to relax muscles. The recall was initiated on September 26 after the USFDA reported an “out-o

See Full Page